Venkateswarlu Kondragunta
7Patents
3h-index
5Co-inventors
50Inventor score
Filing activity: Dec 2, 2002 → Sep 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10571467B2 | Methods for prediction of anti-TNFα drug levels and autoantibody formation | Physics | 11 | Active |
| US10324088B2 | Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease | Physics | 8 | Active |
| US7640113B2 | Methods and apparatus for complex genetics classification based on correspondence analysis and linear/quadratic analysis | Physics | 7 | Expired |
| US11162943B2 | Methods for assessing mucosal healing in Crohn's disease patients | Emerging Cross-Sectional Technologies | 2 | Active |
| US11435347B2 | Methods for prediction of anti-TNF α drug levels and autoantibody formation | Physics | 0 | Active |
| US11796541B2 | Methods for assessing mucosal healing in ulcerative colitis disease patients | Emerging Cross-Sectional Technologies | 0 | Active |
| US12422432B2 | Methods for assessing mucosal healing in inflammatory bowel disease patients | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.